TSC22D1: A Potential Drug Target for Tissue Development and Maintenance

Target Name: TSC22D1

NCBI ID: G8848

TSC22D1

TSC22D1: A Potential Drug Target for Tissue Development and Maintenance

TSC22D1 (T22D1_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and muscle. It is a member of the TSC2 gene family, which is known for its role in the development and maintenance of tissues during development and throughout life.

TSC22D1 is a 22-kDa protein that is expressed in the brain, pancreas, and muscle. It is highly conserved across various species, and its only encoded amino acid is Glu-219. TSC22D1 is a cell surface protein, and it is expressed in most tissues of the body, including the brain, pancreas, and muscle.

TSC22D1 is involved in several cellular processes that are critical for normal tissue development and function. It is a negative regulator of the Wnt signaling pathway, which is a critical pathway for the development and maintenance of tissues during development and throughout life.

TSC22D1 is also involved in the regulation of theNotch signaling pathway, which is a critical pathway for the development and maintenance of tissues during development and throughout life.

TSC22D1 is a protein that is known to play a critical role in the development and maintenance of tissues during development and throughout life. It is a potential drug target (or biomarker) due to its involvement in several cellular processes that are critical for normal tissue development and function.

Protein Name: TSC22 Domain Family Member 1

Functions: Transcriptional repressor (PubMed:10488076). Acts on the C-type natriuretic peptide (CNP) promoter (PubMed:9022669)

The "TSC22D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSC22D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets